Surgical Science Sweden ABSUSRF -2.20%82 PEG Ratio is 1.34 as of Jun. 28, 2026, which is 26% above its 10-year median of 1.06. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $19.33 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 225 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks better than 58.22% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Surgical Science Sweden AB's PEG Ratio or its related term are showing as below:
SUSRF'
s PEG Ratio Range Over the Past 10 Years
Min: 0.39 Med: 1.06 Max: 13.75
Current: 1.15
During the past 11 years, Surgical Science Sweden AB's highest PEG Ratio was 13.75. The lowest was 0.39. And the median was 1.06.
SUSRF's PEG Ratio is ranked better than 58.22% of 225
companies
in the Healthcare Providers & Services industry
Industry Median: 1.37
vs SUSRF: 1.15
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Surgical Science Sweden AB (OTCPK:SUSRF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Surgical Science Sweden AB PEG Ratio Related Terms
Surgical Science Sweden AB PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Surgical Science Sweden AB's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Surgical Science Sweden AB (SUSRF) has a PEG Ratio of 1.34 as of Jun. 28, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Surgical Science Sweden AB and its competitors. This is 26% above median its historical median of 1.06. Over the past decade, Surgical Science Sweden AB's PEG Ratio has ranged from 0.39 to 13.75. According to the industry distribution chart, Surgical Science Sweden AB ranks #94 out of 225 companies in the Healthcare Providers & Services industry, placing it in the top 41.8%.
Is Surgical Science Sweden AB's PEG Ratio too high?
Surgical Science Sweden AB's current PEG Ratio of 1.34 is 26% above median its 10-year median of 1.06. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 13.75. The Healthcare Providers & Services industry median PEG Ratio is 1.37. Surgical Science Sweden AB's value of 1.34 is 2.2% below this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #94 out of 225 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's PEG Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #94 out of 225 companies for PEG Ratio. This puts Surgical Science Sweden AB in the upper half of its industry. The industry median PEG Ratio is 1.37. Surgical Science Sweden AB's value of 1.34 is 2.2% below this benchmark. Historically, Surgical Science Sweden AB's own PEG Ratio has ranged from 0.39 to 13.75 over the past decade. While the company's 10-year median is 1.06 vs. the industry median of 1.37, Surgical Science Sweden AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.37, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current PEG Ratio of 1.34 is 2.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Surgical Science Sweden AB and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current PEG Ratio is 1.34, which is 26% above median its own 10-year median of 1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.33, compared to a current price of $4.00 — trading 79.3% below its estimated fair value. The current PEG Ratio is 1.34, which is 26% above median its 10-year median of 1.06 and 2.2% below the Healthcare Providers & Services industry median of 1.37. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current PEG Ratio is 1.34 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of $4.00 is trading 79.3% below its estimated GF Value™ of $19.33.
GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.
Key valuation signals for SUSRF:
PEG Ratio: 1.34 (26% above median its 10-year median of 1.06)
GF Value™: $19.33 vs. price of $4.00 (79.3% below fair value)
Industry Position: 2.2% below the Healthcare Providers & Services median (#94 of 225)
No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score
Get the complete analysis for SUSRF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SUSRF has been successfully added to your 
